Sign in / Join Now
ETFs & Funds
Submits IND For Anti-Psoriasis Drug, And Enrollment Starts For Phase 2b Antibiotic $
I think that by this summer price should double
It will be nice watching this site as the trials get added. $
should have four listed by end of 2014.
Add a reply...
Latest StockTalks »
people get CTIX breaking news and analysis by email alert.
Get email alerts on CTIX »
Get latest price
From other sites
Cellceutix Completes Enrollment In Second Of Three Planned Cohorts In Phase 2 Clinical Trial Of Brilacidin For Inflammatory Bowel Disease
at TheStreet (Tue, 10:00AM)
Cellceutix To Present At Biotech Showcase 2017; Brilacidin For Oral Mucositis Nears Interim Results
at TheStreet (Jan 4, 2017)
Cellceutix Wishes Shareholders Happy Holidays, Prepares For 2017 Focused On Partnerships
at TheStreet (Dec 22, 2016)
Cellceutix Reports 24 Core Phase 2b Clinical Trial Sites For Oral Prurisol Treatment Of Moderate-To-Severe Psoriasis Initiated And Open For Screening
at TheStreet (Dec 19, 2016)
Cellceutix Reports Advances In Developing Kevetrin As An Oral Ovarian Cancer Treatment; Company Seeks To Develop World's First P53-Modulating Oral Cancer Drug
at TheStreet (Dec 15, 2016)